^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

LDHB overexpression

i
Other names: LDHB, L-lactate dehydrogenase B chain, LDH heart subunit, LDH-H, Renal carcinoma antigen NY-REN-46, Testicular secretory protein Li 25, Epididymis secretory protein Li 281, Lactate dehydrogenase H chain, TRG-5, HEL-S-281
Entrez ID:
Related biomarkers:
3ms
Transcription Factor STAT3-Activated LDHB Promotes Tumor Properties of Endometrial Cancer Cells by Inducing MDH2 Expression. (PubMed, Mol Biotechnol)
Moreover, MDH2 overexpression rescued LDHB knockdown-induced effects on EC cell phenotypes. STAT3-activated LDHB promoted endometrial cancer cell malignancy by inducing MDH2 production.
Journal
|
LDHB (L-lactate dehydrogenase B chain) • STAT3 (Signal Transducer And Activator Of Transcription 3)
|
LDHB overexpression
9ms
LDHA and LDHB overexpression promoted the Warburg effect in malignantly transformed GES-1 cells induced by N-nitroso compounds. (PubMed, Food Chem Toxicol)
Knocking down LDHA and LDHB together fully suppressed lactate secretion and effectively suppressed the malignant phenotype of cells transformed by long-term MNNG exposure. Finally, we demonstrated that overexpression of LDHA and LDHB promotes the malignant transformation of GES-1 cells by enhancing the Warburg effect during long-term exposure to NOCs.
Journal
|
LDHA (Lactate dehydrogenase A) • LDHB (L-lactate dehydrogenase B chain)
|
LDHB overexpression
over1year
Integrative analysis of plasma metabolomics and proteomics reveals the metabolic landscape of breast cancer. (PubMed, Cancer Metab)
This study uncovered specific changes in the metabolic and proteomic profiling of breast cancer patients and identified a panel of 47 plasma metabolites, including sphingomyelins, glutamate, and cysteine could be potential diagnostic biomarkers for breast cancer.
Journal
|
LDHB (L-lactate dehydrogenase B chain)
|
LDHB overexpression
3years
HYOU1 facilitates proliferation, invasion and glycolysis of papillary thyroid cancer via stabilizing LDHB mRNA. (PubMed, J Cell Mol Med)
While LDHB overexpression significantly suppressed the inhibitory effects of HYOU1 silencing on aerobic glycolysis, proliferation, migration and invasion in PTC cells. Taken together, our findings suggest that HYOU1 promotes glycolysis and malignant progression in PTC cells via upregulating LDHB expression, providing a potential target for developing novel anticancer agents.
Journal
|
LDHB (L-lactate dehydrogenase B chain) • MIR375 (MicroRNA 375)
|
LDHB overexpression